MCI/ PLMCIMG00012 /
| 2024-05-22 4:21:30 PM | Chg. -0.40 | Volume | Bid4:21:30 PM | Ask4:21:30 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 26.80PLN | -1.47% | 2,716 Turnover: 72,640.90 |
26.80Bid Size: 604 | 27.00Ask Size: 506 | 1.39 bill.PLN | 2.61% | 9.68 |
GlobeNewswire
05-21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
05-20
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI)...
GlobeNewswire
05-17
NFI subsidiary New Flyer announces contract with BC Transit for 33 battery-electric buses
GlobeNewswire
05-15
AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Lon...
GlobeNewswire
05-15
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire
05-14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
05-13
New Jersey awards NFI subsidiary New Flyer a contract for up to 1,300 Xcelsior® Transit Buses
GlobeNewswire
05-13
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting ...
GlobeNewswire
05-12
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
05-10
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsi...
GlobeNewswire
05-09
Investors in Anavex Life Sciences Corporation Should Contact The Gross Law Firm Before May 13, 2024 ...
GlobeNewswire
05-09
ANAVEX ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fil...
GlobeNewswire
05-08
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
GlobeNewswire
05-07
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsi...
GlobeNewswire
05-06
NFI announces Election of Directors, including new Board member Anne Marie O’Donovan
GlobeNewswire
05-03
Contact Levi & Korsinsky by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences ...
GlobeNewswire
05-02
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
05-02
May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL
GlobeNewswire
05-01
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
GlobeNewswire
04-30
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, M...
GlobeNewswire
04-29
Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate D...
